Almeida, Paulo H R F <br/><br/>
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.  [electronic resource] 

 -  The patient  08 2018 
 - 377-389 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1178-1661 
<br/><br/><label>Standard No.: </label>10.1007/s40271-017-0291-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose<br/>Brazil<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Glycated Hemoglobin<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin Glargine--adverse effects<br/>Insulin, Isophane--adverse effects<br/>Patient Satisfaction<br/>Quality of Life